Makoto Akiyoshi

Makoto Akiyoshi


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2017 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
MAMakoto Akiyoshi
Makoto Akiyoshi
MHMasaharu Hisasue
Masaharu Hisasue
MAMasami Akiyoshi
Masami Akiyoshi
Canine primary hypoplasia of the portal vein (PHPV) is a microscopic malformation of the hepatic vasculature. The prevalence, clinical signs, and clinicopathological findings of PHPV in dogs are unclear, because there are few reports concerning PHPV in the veterinary literature. This retrospective study reviewed clinical records and liver biopsy data from 48 dogs with hepatic disease that were examined at a private veterinary hospital in Japan between April 2011 and March 2014 to determine the prevalence of PHPV among dogs that underwent liver biopsy and to determine the clinical and clinicopathological findings of PHPV in dogs. Records for all 48 dogs that underwent liver biopsy were investigated. Collected data included signalment, clinical signs, physical examination findings, complete blood cell count, chemistry results, pre-and postprandial serum total bile acid concentrations, coagulation profiles (prothrombin time, activated partial thromboplastin time, fibrinogen, and antithrombin), and abdominal ultrasonography findings at the first medical examination. The diagnosis of PHPV was made on the basis of histological examination of hepatic biopsy specimens and portography or CT angiography. Among the 48 canine cases, 28 dogs (58.3%) were diagnosed with PHPV, which was the most common diagnosis. The most frequent clinical sign in dogs with PHPV was asymptomatic persistently increased liver enzymes (57.1%). Toy poodles were at a significantly higher risk of PHPV than other breeds among dogs that underwent liver biopsy (P < 0.001). The median survival time of dogs with PHPV was more than 5 years. Plasma fibrinogen concentration below the reference range was an indicator of PHPV in this study. Dogs with PHPV frequently had mild clinical signs and a favorable prognosis.

1 January 2023 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
MAMakoto Akiyoshi
Makoto Akiyoshi
MHMasaharu Hisasue
Masaharu Hisasue
SNSakurako Neo
Sakurako Neo
MAMasami Akiyoshi
Masami Akiyoshi
The incidence of feline gastrointestinal (GI) lymphoma has recently increased. Serum amyloid A (SAA) levels are elevated in feline lymphoma. However, no reports have evaluated SAA concentrations and outcomes in feline GI lymphoma. This study aimed to evaluate the clinical utility of SAA and other factors in feline GI lymphoma to assess the outcomes with potential differences. The study included 39 client-owned cats diagnosed with GI lymphoma, which were divided into two groups: high- and low-grade lymphomas. Changes in SAA concentration, complete blood count (CBC), and biochemical profiles were analyzed at the time of initial presentation as well as on days 1, 28, and 56. Differences between the two groups were investigated. High-grade lymphoma was observed in 17 cats, whereas 22 cats showed low-grade lymphoma. SAA concentrations on the day of initial presentation were significantly higher in low-grade lymphoma than those in high-grade lymphoma (median, 12.4 µg/mL; range, 4.8–46.5 µg/mL vs 3.8 µg/mL; 3.8–13.7 µg/mL; P=0.011). Elevated SAA concentration on day 56 in high-grade GI lymphoma was a poor prognostic factor. (Hazard Ratio = 1.012, per 1 µg/mL increase; 95% confidence interval; 1.004–1.020, P=0.002). The SAA concentration on the day of initial presentation did not serve as a suitable prognostic factor and did not depend on the grade or stage of the lymphoma. However, continuous SAA concentration measurement may be useful for predicting the outcome of feline GI lymphoma.

27 February 2019 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
MAMakoto Akiyoshi
Makoto Akiyoshi
MHMasaharu Hisasue
Masaharu Hisasue
SNSakurako Neo
Sakurako Neo
MAMasami Akiyoshi
Masami Akiyoshi
YGYuko Goto‐Koshino
Yuko Goto‐Koshino

31 July 2022 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
MAMakoto Akiyoshi
Makoto Akiyoshi
MHMasaharu Hisasue
Masaharu Hisasue
MAMidori Goto Asakawa
Midori Goto Asakawa
SNSakurako Neo
Sakurako Neo
MAMasami Akiyoshi
Masami Akiyoshi

2 March 2021 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
MAMakoto Akiyoshi
Makoto Akiyoshi
MHMasaharu Hisasue
Masaharu Hisasue
SNSakurako Neo
Sakurako Neo
MAMasami Akiyoshi
Masami Akiyoshi

17 August 2021 in Veterinary Medicine and Science
Verified
Journal Article
Open access
PDF file
MAMakoto Akiyoshi
Makoto Akiyoshi
MAMasami Akiyoshi
Masami Akiyoshi
A 7-year-old spayed female Scottish Fold cat presented with a 4-week history of anorexia, weight loss and vomiting. Abdominal ultrasonography revealed a jejunal mass and a slightly enlarged jejunal lymph node. A fine-needle aspiration of the mass revealed many round cells with multiple small intracytoplasmic magenta granules. The mass was diagnosed as a large granular lymphocyte (LGL) lymphoma based on cytology. The LGL lymphoma was completely resected via open surgery. The histologic and cytologic evaluations showed no neoplastic findings in the jejunal lymph node, liver, spleen, kidney or bone marrow. The LGL lymphoma was localized to the jejunum. Postoperatively, the cat received chemotherapy with nimustine, L-asparaginase and prednisolone. The cat is currently receiving nimustine every 6 weeks, without adverse events, and treatment has been administrated a total of 18 times up until day 552. The cat is in a good condition, and the LGL lymphoma has not recurred. Nimustine should be considered one of the effective chemotherapeutic agents in the treatment of feline LGL lymphoma cases in the future.